1 Min Read
April 25 (Reuters) - Phaserx Inc
* Phaserx receives positive opinion for orphan drug designation for PRX-OTC from european medicines agency Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.